Hecker, Michael http://orcid.org/0000-0001-7015-3094
Fitzner, Brit
Jäger, Kathrin
Bühring, Jan
Schwartz, Margit
Hartmann, Alexander
Walter, Michael
Zettl, Uwe Klaus
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 9 December 2020
Accepted: 26 January 2021
First Online: 5 February 2021
Declarations
:
: MH received speaking fees and travel funds from Bayer HealthCare, Biogen, Merck, Novartis, and Teva. UKZ received research support as well as speaking fees and travel funds from Almirall, Bayer HealthCare, Biogen, Merck Serono, Novartis, Sanofi Genzyme, and Teva. BF, KJ, JB, MS, AH, and MW declare that they have no competing interests.
: The study was approved by the University of Rostock’s ethics committee. All subjects gave their prior consent to the use of residual blood samples for research purposes.
: Not applicable.